Organic compositions to treat HSF1-related diseases
US12091661B2 · kind B2 · utility
0Cited by
17References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2022 |
| Grant date | Sep 17, 2024 |
| Priority date | — |
| Expiry date | Apr 6, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.